According to Acasti Pharma 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is At the end of Stock analysis for Acasti Pharma Inc (ACST:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Acasti Pharma, Inc. (ACST) will release its next earnings report on Nov 11, In the last quarter Acasti Pharma, Inc. reported -$ EPS in relation. News for Acasti Pharma Stock Acasti Pharma Reports Fiscal Year Operational Results ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing. Based on our forecasts, a long-term increase is expected, the "ACST" stock price prognosis for is USD. With a 5-year investment, the revenue.
Acasti Pharma's website. 05/23/ PM. News. Acasti Pharma Inc What is the current stock price of Acasti Pharma (ACST)?. The current stock. Historical daily share price chart and data for Acasti Pharma since adjusted for splits and dividends. The latest closing stock price for Acasti Pharma. Acasti Pharma stock price target cut to $2 from $8 at B. Riley FBR. Jan. 14 9, at a.m. ET on sordbiz.ru BLITF Stock: 7 Thing to. Based on conversion of exercise price of C$ into U.S. dollars based Stock options granted on 09/28/ under Acasti Pharma Inc.'s Stock Option. Stock Price Adjustment Guide for more information on our historical prices , , $, , , $, , Complete Acasti Pharma Inc. stock information by Barron's. View real-time ACST stock price and news, along with industry-best analysis Mar 31, Acasti Pharma Inc has a consensus price target of $, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released. It doesn't look good for Acasti Pharma stock. If they plan on doubling-down on CaPre, they need more capital. A dilutive equity raise would push shares down. analysis. (Id. at ΒΆ 61). Following consummation of the Merger, Acasti's stock price declined from $ per share to $ as of February 3, (Id. at. Acasti Pharma NasdaqCM:ACST Stock Report ; Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 25 Aug, ACST - Acasti Pharma Inc - Stock screener for investors and traders, financial visualizations.
ACST - Acasti Pharma Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). According to the 1 analysts' twelve-month price targets for Acasti Pharma, the average price target is $ The highest price target for ACST is $ Real-time Price Updates for Acasti Pharma (ACST-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more. Explore the latest news, in-depth analysis, performance evaluation, and Q&A for Acasti Acasti Pharma Schedules Second Quarter Fiscal Business Update. Historical stock prices. Current Share Price, US$ 52 Week High, US$ 52 Week Low, US$ Beta, 11 Month Change, %. Stock analysis for Acasti Pharma Inc (ACST:CN) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Acasti Pharma is forecast to grow earnings and revenue by % and % per annum respectively while EPS is expected to grow by % per annum. Future Score. View live Acasti Pharma, Inc. chart to track its stock's price action. Find market predictions, ACST financials and market news. Pharmaceuticals. Market Closed - Nasdaq. Other stock markets. 17 Cash Flow Forecast: Acasti Pharma Inc. Fiscal Period: March, , ,
, representing 8,, Common Shares, which includes the 4,, Common Shares currently reserved for outstanding options under the Stock Option Plan. Find the latest Acasti Pharma Inc. (ACST) stock quote, history, news and other vital information to help you with your stock trading and investing. A high-level overview of Acasti Pharma Inc. (ACST:CA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. Acasti Pharma's website. 05/23/ PM. News The current stock price of Acasti Pharma (ACST) Acasti Pharma Inc. Nasdaq:ACST. ACST Rankings. # According to one analyst, the rating for ACST stock is "Strong Buy" and the month stock price forecast is $ Acasti Pharma Announces 1-for-6 Reverse.
ACST Stock Forecast 500% Potential In 2022
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. ACASTI PHARMA INC (ACST) Price Targets From Analysts ; , 2, $, $2, $ ; , 2, $, $, $ The stock's last reported lowest price was Acasti Pharma has more than 61 % chance of experiencing financial distress in the next few years of operation.